🇺🇸 TMC114 in United States

128 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pyrexia — 20 reports (15.62%)
  2. Immune Reconstitution Syndrome — 19 reports (14.84%)
  3. Renal Failure — 14 reports (10.94%)
  4. Dehydration — 13 reports (10.16%)
  5. Pancreatitis — 13 reports (10.16%)
  6. Diarrhoea — 12 reports (9.38%)
  7. Hepatitis — 10 reports (7.81%)
  8. Pneumonia — 10 reports (7.81%)
  9. Renal Failure Acute — 9 reports (7.03%)
  10. Alanine Aminotransferase Increased — 8 reports (6.25%)

Source database →

Other Infectious Diseases approved in United States

Frequently asked questions

Is TMC114 approved in United States?

TMC114 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for TMC114 in United States?

Tibotec Pharmaceuticals, Ireland is the originator. The local marketing authorisation holder may differ — check the official source linked above.